Meloxicam and indomethacin activity on human matrix metalloproteinases in synovial fluid

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 665-666

  Barracchini, A ^a   Franceschini, N ^a   Minisola, G ^a,b   Pantaleoni, G C ^a   Di Giulio, A ^a   Oratore, A ^a   Amicosante, G ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Villa Betania Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME INHIBITION; HUMAN; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0032839690     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07756.x     Document Type: Conference Paper

References (5)

1. 1. Cawston, T.E. 1996. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70: 163-182.
2. 2. Vincenti, M.P., I.M. Clark & C.E. Brinckerhoff. 1994. Using inhibitors of metalloproteinases to treat arthritis. Arthritis Rheum. 8: 1115-1126.
3. 3. Knight, C.G., F. Willenbrock & G. Murphy. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296: 263-266.
4. 4. Di Giulio, A., A. Barracchini, L. Cellai, C. Martuccio, G. Amicosante, A. Oratore & G.C. Pantaleoni. 1996. Rifamycins as inhibitors of collagenase activity: their possible pharmacological role in collagen degradative diseases. Int. J. Pharm. 144: 27-35.
5. 5. Brooks, P. & G. Lee. 1998 The therapy of rheumatic diseases. In Textbook of Clinical Rheumatology. H.S. Howe & P.H. Feng, Eds.: 389-417. National Arthritis Foundation. Singapore.